This study reports the results of a Japanese clinical trial of transcatheter closure of atrial
septal defects (ASD) using the Amplatzer septal occluder (ASO). Thirty-five patients with …

BACKGROUND: The Amplatzer Septal Occluder (ASO)(AGA Medical Corp, Golden Valley,
Minn) has gained wide acceptance for transcatheter closure of atrial septal defect (ASD). We …

Abstract Between June 1999 and September 2002, 45 patients (age, 34±13 years; mean
shunt ratio, 2.6±0.6) underwent transcatheter atrial septal defect (ASD) closure at our …

Amplatzer septal occluder (AGA Med. Co., USA) is a novel device for occlusion of atrial
septal defect. We present our experience of transcatheter closure of atrial septal defects …

Background and Objectives Transcatheter occlusion (TCO) may be an alternative method for
the surgical closure of a secundum atrial septal defect (ASD) below 20 mm in diameter. We …

Aims Transcatheter closure of secundum atrial septal defects (ASD) with the Amplatzer
septal occluder (ASO) has become a standard procedure in most pediatric and adult …

The impact of device size choice on closure results was analyzed in 138 (101 females, 37
males; age 0.5–84.0 years) consecutive patients who underwent transcatheter closure of the …

Transcatheter closure of atrial septal defects (ASDs) was performed mainly in children and
adolescents. Information about outcome and complications in adults was limited. From …

Objective To evaluate the safety and efficacy of the Amplatzer septal occluder for
transcatheter closure in patients with secundum atrial septal defect (ASD Ⅱ). Methods …

Our study reports the results of a comparison of closure of atrial septal defect (ASD)
surgically with transcatheter closure using the Amplatzer septal occluder. Patients having an …